Kunert, Jan-Philip https://orcid.org/0000-0001-6149-7119
Müller, Max
Günther, Thomas
Stopper, León
Urtz-Urban, Nicole
Beck, Roswitha
Wester, Hans-Jürgen
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SFB824, Project B11 an Z01)
Technische Universität München
Article History
Received: 28 July 2022
Accepted: 15 October 2022
First Online: 16 January 2023
Declarations
:
: All animal experiments were conducted in accordance with general animal welfare regulations in Germany (German animal protection act, in the edition of the announcement, dated May 18th, 2006, as amended by Article 280 of June 19th 2020, approval no. ROB-55.2-1-2532.Vet_02-18-109 by the General Administration of Upper Bavaria) and the institutional guidelines for the care and use of animals. The study was carried out in compliance with the ARRIVE guidelines. This article does not contain any studies with human participants.
: Not applicable.
: JPK and HJW are listed as inventors in patent applications for some silicon-containing PSMA compounds. HJW receives funding from the SFB 824 (Deutsche Forschungsgemeinschaft, Bonn, Germany, Sonderforschungsbereich 824, Project B11 and Z01). HJW is founder and shareholder of Scintomics GmbH, Fuerstenfeldbruck, Germany. No other potential conflicts of interest relevant to this article exist.